Name: Latest research reports of Aurobindo Pharma Ltd. authored by Prabhudas Lilladhar and published by - Trendlyne research reports.
Item: Aurobindo Pharma Ltd.
Rating: 4
Author: Prabhudas Lilladhar

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report	Discuss
	18 Sep 2025	Aurobindo Pharma	Consensus Share Price Target	1095.70	1293.39	-	18.04	buy	pdf Detailed Estimates
	14 Aug 2023	Aurobindo Pharma	Prabhudas Lilladhar Reco Target	1095.70	900.00	871.65 (25.70%)	Target met	Accumulate	pdf post cache	Broker Report AUROBINDO PHARMA Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	14 Aug 2023	Aurobindo Pharma	Motilal Oswal Target	1095.70	910.00	871.65 (25.70%)	Target met	Neutral	pdf post cache	Broker Report US/EU markets drive profitability Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	30 May 2023	Aurobindo Pharma	Sharekhan Target	1095.70	716.00	650.75 (68.37%)	Target met	Hold	pdf post cache	Broker Report Aurobindo Pharm Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	30 May 2023	Aurobindo Pharma	ICICI Securities Limited Target	1095.70	655.00	650.75 (68.37%)	Target met	Accumulate	pdf post cache	Broker Report Better pricing, launches to improve US traction ICICI Securities Limited Aurobindo Pharma’s (Aurobindo) Q4FY23 result was slightly better than our expectation. We believe US dynamics is set to improve as product withdrawal by some companies is driving volumes and stability in pricing. pdf Copy Link Share on Share on Share on Share on Alert
	30 May 2023	Aurobindo Pharma	Axis Direct Reco Target	1095.70	700.00	650.75 (68.37%)	Target met	Buy	pdf post cache	Broker Report Result Update:Aurobindo Pharma Axis Direct We change our rating to BUY with TP: Rs 700/share pdf Copy Link Share on Share on Share on Share on Alert
	29 May 2023	Aurobindo Pharma	ICICI Direct Target	1095.70	615.00	611.30 (79.24%)	Target met	Hold	pdf post cache	Broker Report Aurobindo Pharma Limited ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	29 May 2023	Aurobindo Pharma	Prabhudas Lilladhar Target	1095.70	660.00	611.30 (79.24%)	Target met	Buy	pdf post cache	Broker Report AUROBINDO PHARMA Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	29 May 2023	Aurobindo Pharma	Motilal Oswal Reco Target	1095.70	600.00	611.30 (79.24%)	Target met	Neutral	pdf post cache	Broker Report Earnings decline for second consecutive year Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	02 Mar 2023	Aurobindo Pharma	Geojit BNP Paribas Target	1095.70	554.00	462.90 (136.70%)	Target met	Buy	pdf post cache	Broker Report AUROBINDO PHARMA LTD Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	11 Feb 2023	Aurobindo Pharma	BOB Capital Markets Ltd. Target	1095.70	635.00	468.85 (133.70%)	Target met	Buy	pdf post cache	Broker Report Aurobindo Pharma (BUY): Modest Q3; no respite on margin front BOB Capital Markets Ltd. Q3 revenue up 7% YoY to Rs 64bn led by growth in the US and EMs along with recovery in ARV business pdf Copy Link Share on Share on Share on Share on Alert
more loading

29.76% Fall from 52W High

Aurobindo Pharma Ltd. share price target

Aurobindo Pharma Ltd. has an average share price target of 1403.50. The consensus estimate represents an upside of 28.09% from the last price of 1095.70. View 17 reports from 10 analysts offering long-term price targets for Aurobindo Pharma Ltd..

AUROBINDO PHARMA

US/EU markets drive profitability

Aurobindo Pharm

Better pricing, launches to improve US traction

Result Update:Aurobindo Pharma

Aurobindo Pharma Limited

AUROBINDO PHARMA

Earnings decline for second consecutive year

AUROBINDO PHARMA LTD

Aurobindo Pharma (BUY): Modest Q3; no respite on margin front

Advisor Screeners